Schizophrenia drug combined with radiation shows promise in treating deadly brain tumors

Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors. The findings, published in Proceedings of the National Academy of Sciences, show…

Details

Infectious disease modeling study casts doubt on impact of Justinianic plague

ANNAPOLIS, Md. – Many have claimed the Justinianic Plague (c. 541-750 CE) killed half of the population of Roman Empire. Now, historical research and mathematical modeling challenge the death rate and severity of this first plague pandemic. Researchers Lauren White, PhD and Lee Mordechai, PhD, of the University of Maryland’s National Socio-Environmental Synthesis Center (SESYNC),…

Details

NIH invests in rapid innovation and development for COVID-19 testing

UMass Medical School and UMass Lowell will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies via their Center for Advancing Point of Care Technologies collaboration. With a $1.5 billion investment from federal stimulus funding, the newly launched Rapid Acceleration of…

Details

Labs Across U.S. Join Federal Initiative to Study Coronavirus Genome

The Centers for Disease Control and Prevention on Thursday announced a national initiative to speed research into how the coronavirus was spreading around the country, bringing together at least 75 public health, academic and commercial institutions studying its genome. As the virus replicates, tiny mutations accumulate in its genetic code. Those differences help scientists trace…

Details